NGM Annual Operating Expenses
$155.88 M
-$65.70 M-29.65%
31 December 2023
Summary:
As of February 3, 2025, NGM annual total operating expenses is $155.88 million, with the most recent change of -$65.70 million (-29.65%) on December 31, 2023. During the last 3 years, it has fallen by -$35.32 million (-18.47%).NGM Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Quarterly Operating Expenses
$29.83 M
-$1.78 M-5.65%
31 December 2023
Summary:
As of February 3, 2025, NGM quarterly total operating expenses is $29.83 million, with the most recent change of -$1.78 million (-5.65%) on December 31, 2023. Over the past year, it has dropped by -$22.61 million (-43.12%).NGM Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NGM Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.6% | -43.1% |
| 3 y3 years | -18.5% | -37.1% |
| 5 y5 years | +38.0% | -12.4% |
NGM Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -29.7% | -47.2% |
NGM Biopharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $155.88 M(-29.7%) | $29.83 M(-5.6%) |
| Sept 2023 | - | $31.61 M(-24.7%) |
| June 2023 | - | $42.00 M(-19.9%) |
| Mar 2023 | - | $52.44 M(-7.1%) |
| Dec 2022 | $221.58 M(+11.6%) | $56.48 M(+0.5%) |
| Sept 2022 | - | $56.22 M(+1.5%) |
| June 2022 | - | $55.36 M(+3.4%) |
| Mar 2022 | - | $53.53 M(+11.1%) |
| Dec 2021 | $198.58 M(+3.9%) | $48.18 M(+1.3%) |
| Sept 2021 | - | $47.58 M(-10.9%) |
| June 2021 | - | $53.39 M(+8.0%) |
| Mar 2021 | - | $49.42 M(+4.2%) |
| Dec 2020 | $191.20 M | $47.44 M(-11.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $53.44 M(+18.0%) |
| June 2020 | - | $45.29 M(+0.6%) |
| Mar 2020 | - | $45.03 M(-6.9%) |
| Dec 2019 | $152.88 M(+35.3%) | $48.38 M(+40.0%) |
| Sept 2019 | - | $34.56 M(-1.4%) |
| June 2019 | - | $35.05 M(+0.4%) |
| Mar 2019 | - | $34.89 M(+2.4%) |
| Dec 2018 | $112.98 M(+19.5%) | $34.06 M(+16.3%) |
| Sept 2018 | - | $29.28 M(+11.3%) |
| June 2018 | - | $26.30 M(+12.8%) |
| Mar 2018 | - | $23.33 M |
| Dec 2017 | $94.57 M(+0.7%) | - |
| Dec 2016 | $93.95 M | - |
FAQ
- What is NGM Biopharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual operating expenses year-on-year change?
- What is NGM Biopharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly operating expenses year-on-year change?
What is NGM Biopharmaceuticals annual total operating expenses?
The current annual operating expenses of NGM is $155.88 M
What is the all time high annual operating expenses for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual total operating expenses is $221.58 M
What is NGM Biopharmaceuticals annual operating expenses year-on-year change?
Over the past year, NGM annual total operating expenses has changed by -$65.70 M (-29.65%)
What is NGM Biopharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of NGM is $29.83 M
What is the all time high quarterly operating expenses for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly total operating expenses is $56.48 M
What is NGM Biopharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, NGM quarterly total operating expenses has changed by -$22.61 M (-43.12%)